First human test of new NASH drug begins in healthy women
Knowledge-focused
Completed
This early-phase study tested a single dose of the experimental drug J2H-1702 in 16 healthy women aged 19 to 45. The main goal was to check safety and how the drug moves through the body. This is a first step toward possibly treating non-alcoholic steatohepatitis (NASH), a seriou…
Phase: PHASE1 • Sponsor: J2H Biotech • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:01 UTC